Human medicines European public assessment report (EPAR): Prasugrel Mylan, prasugrel, Myocardial Infarction,Acute Coronary Syndrome,Angina, Unstable, Date of authorisation: 15/05/2018, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Clopidogrel ratiopharm GmbH, clopidogrel, Peripheral Vascular Diseases,Acute Coronary Syndrome,Myocardial Infarction,Stroke, Date of authorisation: 28/07/2009, Revision: 12, Status: Authorised

Case Medical Research ◽

10.31525/cmr-15997e4 ◽

2019 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Vascular Diseases ◽

Peripheral Vascular ◽

Assessment Report ◽

Peripheral Vascular Diseases ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Clopidogrel Zentiva (previously Clopidogrel Winthrop), clopidogrel, Stroke,Peripheral Vascular Diseases,Myocardial Infarction,Acute Coronary Syndrome, Date of authorisation: 15/07/2008, Revision: 23, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871bf ◽

2018 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Vascular Diseases ◽

Peripheral Vascular ◽

Assessment Report ◽

Peripheral Vascular Diseases ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel / acetylsalicylic acid, Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 14/03/2010, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5cfca6 ◽

2019 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Acetylsalicylic Acid ◽

Assessment Report ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Plavix, clopidogrel, Stroke,Peripheral Vascular Diseases,Atrial Fibrillation,Myocardial Infarction,Acute Coronary Syndrome, Date of authorisation: 15/07/1998, Revision: 38, Status: Authorised

Case Medical Research ◽

10.31525/cmr-56e525 ◽

2018 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Atrial Fibrillation ◽

Acute Coronary Syndrome ◽

Vascular Diseases ◽

Peripheral Vascular ◽

Assessment Report ◽

Peripheral Vascular Diseases ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Iscover, clopidogrel, Stroke,Peripheral Vascular Diseases,Atrial Fibrillation,Myocardial Infarction,Acute Coronary Syndrome, Date of authorisation: 14/07/1998, Revision: 39, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587216 ◽

2018 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Atrial Fibrillation ◽

Acute Coronary Syndrome ◽

Vascular Diseases ◽

Peripheral Vascular ◽

Assessment Report ◽

Peripheral Vascular Diseases ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover), clopidogrel / acetylsalicylic acid, Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 14/03/2010, Revision: 21, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871d4 ◽

2018 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Acetylsalicylic Acid ◽

Assessment Report ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover), clopidogrel / acetylsalicylic acid, Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 14/03/2010, Revision: 21, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399667 ◽

2018 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Acetylsalicylic Acid ◽

Assessment Report ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Plavix, clopidogrel, Stroke,Peripheral Vascular Diseases,Atrial Fibrillation,Myocardial Infarction,Acute Coronary Syndrome, Date of authorisation: 15/07/1998, Revision: 38, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871c6 ◽

2018 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Atrial Fibrillation ◽

Acute Coronary Syndrome ◽

Vascular Diseases ◽

Peripheral Vascular ◽

Assessment Report ◽

Peripheral Vascular Diseases ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Clopidogrel ratiopharm, clopidogrel, Myocardial Infarction,Acute Coronary Syndrome,Peripheral Vascular Diseases,Stroke, Date of authorisation: 18/02/2015, Revision: 7, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1eb534b ◽

2019 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Vascular Diseases ◽

Peripheral Vascular ◽

Assessment Report ◽

Peripheral Vascular Diseases ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report

Human medicines European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate), clopidogrel, Acute Coronary Syndrome,Peripheral Vascular Diseases,Myocardial Infarction,Stroke, Date of authorisation: 27/07/2009, Revision: 12, Status: Authorised

Case Medical Research ◽

10.31525/cmr-56e4fd ◽

2018 ◽

Author(s):

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Vascular Diseases ◽

Peripheral Vascular ◽

Assessment Report ◽

Peripheral Vascular Diseases ◽

Coronary Syndrome ◽

European Public ◽

European Public Assessment Report ◽

Hydrogen Sulphate